Endpoint definition
↥321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
364
Check minimum number of events None
364
Include endpoints
374
Extra metadata
E4_AMYLOIDOSIS
amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
364
Check minimum number of events None
364
Include endpoints
374
Extra metadata
List of similar endpoints to Amyloidosis based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 367 | 189 | 178 |
Unadjusted prevalence (%) | 0.12 | 0.11 | 0.13 |
Mean age at first event (years) | 61.60 | 58.85 | 64.53 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | - | - | - | - |
15 years | - | - | - | - |
5 years | - | - | - | - |
1 year | - | - | - | - |
Index endpoint: E4_AMYLOIDOSIS – Amyloidosis
GWS hits: 4
before Amyloidosis
after Amyloidosis
Loading survival analyses plot
Loading survival analyses table